Sino Biopharmaceutical Ltd
Sino Biopharmaceutical's GHG Emissions Data Preview
In 2023, Sino Biopharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Sino Biopharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Sino Biopharmaceutical's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Sino Biopharmaceutical amounted to 239,239.62 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Sino Biopharmaceutical decreased by 13.66%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Sino Biopharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Sino Biopharmaceutical's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Sino Biopharmaceutical were 17,046.22 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Sino Biopharmaceutical reduced its Scope 1 emissions over time?
Since 2021, Sino Biopharmaceutical's Scope 1 emissions have decreased by 21.49%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Sino Biopharmaceutical's Scope 1 emissions increased by 5.92%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Sino Biopharmaceutical's Scope 2 emissions?
In 2023, Sino Biopharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 222,193.4 tCOâ‚‚e without specifying the calculation method.
Has Sino Biopharmaceutical reduced its Scope 2 emissions over time?
Since 2021, Sino Biopharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 12.25%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Sino Biopharmaceutical's Scope 2 emissions (Unspecified Calculation Method) fell by 14.87% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Sino Biopharmaceutical use for Scope 2 reporting?
In 2023, Sino Biopharmaceutical reported its Scope 2 emissions using an unspecified methodology.
Sino Biopharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)